| Product Code: ETC6176600 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Australia saw a -2.5% decline in imports of cardiotonic agents compared to 2023, with a compound annual growth rate (CAGR) of -10.3% from 2020 to 2024. This negative import momentum can be attributed to shifting demand patterns or changes in market dynamics impacting the cardiotonic agents sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Cardiotonic Agents Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Cardiotonic Agents Market Revenues & Volume, 2022 & 2032F |
3.3 Australia Cardiotonic Agents Market - Industry Life Cycle |
3.4 Australia Cardiotonic Agents Market - Porter's Five Forces |
3.5 Australia Cardiotonic Agents Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Australia Cardiotonic Agents Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Australia Cardiotonic Agents Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.8 Australia Cardiotonic Agents Market Revenues & Volume Share, By Dosage Form, 2022 & 2032F |
3.9 Australia Cardiotonic Agents Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Australia Cardiotonic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Australia |
4.2.2 Growing geriatric population leading to higher demand for cardiotonic agents |
4.2.3 Technological advancements in cardiotonic agents leading to more effective treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of cardiotonic agents |
4.3.2 High cost associated with cardiotonic agents impacting affordability for some patients |
4.3.3 Competition from alternative treatment options such as lifestyle changes and non-pharmacological interventions |
5 Australia Cardiotonic Agents Market Trends |
6 Australia Cardiotonic Agents Market, By Types |
6.1 Australia Cardiotonic Agents Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Cardiotonic Agents Market Revenues & Volume, By Drug Type, 2022-2032F |
6.1.3 Australia Cardiotonic Agents Market Revenues & Volume, By Digitalis Glycosides, 2022-2032F |
6.1.4 Australia Cardiotonic Agents Market Revenues & Volume, By Phosphodiesterase Inhibitors, 2022-2032F |
6.1.5 Australia Cardiotonic Agents Market Revenues & Volume, By Cardioprotectants, 2022-2032F |
6.1.6 Australia Cardiotonic Agents Market Revenues & Volume, By Sympathomimetic Agents, 2022-2032F |
6.1.7 Australia Cardiotonic Agents Market Revenues & Volume, By Others, 2022-2032F |
6.2 Australia Cardiotonic Agents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Cardiotonic Agents Market Revenues & Volume, By Cardiac Surgical Procedures, 2022-2032F |
6.2.3 Australia Cardiotonic Agents Market Revenues & Volume, By Atrial Fibrillation, 2022-2032F |
6.2.4 Australia Cardiotonic Agents Market Revenues & Volume, By Heart Failure, 2022-2032F |
6.2.5 Australia Cardiotonic Agents Market Revenues & Volume, By Pulmonary Hypertension, 2022-2032F |
6.2.6 Australia Cardiotonic Agents Market Revenues & Volume, By Others (Atrial Flutter, Cardiogenic Shock, etc.), 2022-2032F |
6.3 Australia Cardiotonic Agents Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Cardiotonic Agents Market Revenues & Volume, By Oral, 2022-2032F |
6.3.3 Australia Cardiotonic Agents Market Revenues & Volume, By Parenteral, 2022-2032F |
6.4 Australia Cardiotonic Agents Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Australia Cardiotonic Agents Market Revenues & Volume, By Tablet, 2022-2032F |
6.4.3 Australia Cardiotonic Agents Market Revenues & Volume, By Solution, 2022-2032F |
6.4.4 Australia Cardiotonic Agents Market Revenues & Volume, By Others, 2022-2032F |
6.5 Australia Cardiotonic Agents Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Cardiotonic Agents Market Revenues & Volume, By Hospital Pharmacies, 2022-2032F |
6.5.3 Australia Cardiotonic Agents Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
6.5.4 Australia Cardiotonic Agents Market Revenues & Volume, By Online Pharmacies, 2022-2032F |
7 Australia Cardiotonic Agents Market Import-Export Trade Statistics |
7.1 Australia Cardiotonic Agents Market Export to Major Countries |
7.2 Australia Cardiotonic Agents Market Imports from Major Countries |
8 Australia Cardiotonic Agents Market Key Performance Indicators |
8.1 Number of new product launches in the cardiotonic agents market |
8.2 Research and development investment in cardiovascular therapies |
8.3 Adoption rate of advanced cardiotonic agents in clinical practice |
9 Australia Cardiotonic Agents Market - Opportunity Assessment |
9.1 Australia Cardiotonic Agents Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Australia Cardiotonic Agents Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Australia Cardiotonic Agents Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.4 Australia Cardiotonic Agents Market Opportunity Assessment, By Dosage Form, 2022 & 2032F |
9.5 Australia Cardiotonic Agents Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Australia Cardiotonic Agents Market - Competitive Landscape |
10.1 Australia Cardiotonic Agents Market Revenue Share, By Companies, 2025 |
10.2 Australia Cardiotonic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here